Journal of Contemporary Brachytherapy (Aug 2021)
Eligibility criteria according to EAU/ESTRO/SIOG guidelines for exclusive iodine-125 brachytherapy for intermediate-risk prostate adenocarcinoma patients: impact on relapse-free survival
Abstract
No abstracts available.Keywords